Treatment with Bifidobacterium longum 51A attenuates intestinal damage and inflammatory response in experimental colitis.
- 2020-02-19
- Beneficial Microbes 11(1)
- F. A. Abrantes
- B. B. Nascimento
- M. E. Andrade
- P. A. V. de Barros
- C. T. Cartelle
- F. S. Martins
- J. Nicoli
- R. Arantes
- S. Generoso
- S. O. Fernandes
- V. Cardoso
- PubMed: 32066260
- DOI: 10.3920/bm2019.0098
- Low evidence
Bifidobacterium administration in the TT group attenuated severe lesions in the colon and reduced eosinophil peroxidase level (P<0.05).
- Effect
- Beneficial
- Effect size
- Large